Skip to main content
. Author manuscript; available in PMC: 2021 Aug 1.
Published in final edited form as: Int J Cardiol. 2020 Mar 12;312:1–9. doi: 10.1016/j.ijcard.2020.03.028

Table 1:

Patient Characteristics

Patient Characteristics ND DM P values
Age (y)* 73 ± 10 69 ± 9.0 0.40
Number of cases 12 12 1.00
Male n(%) 10 (%) 9 (%) 1.00
HbA1c (%)* 5.3 ± 0.33 8.2 ± 0.84 0.0001
Blood Glucose (mg/dL)* 112 ± 14.0 156 ± 20.2 0.0005
Obesity (BMI>30) n(%) 3 (25.0%) 7 (58.3%) 0.21
Hypertension n(%) 3 (25.0%) 9 (75%) 0.04
Atrial fibrillation n(%) 1 (8.3%) 1 (8.3%) 1.00
Heart failure n(%) 1 (8.3%) 2 (16.7%) 1.00
Hypercholesterolemia n(%) 3 (25.0%) 9 (75%) 0.04
Valve replacement n(%) 9 (75%) 1 (8.3%) 0.003
CABG only n(%) 0 (%) 9 (75%) 0.0003
CABG + Valve replacement n(%) 2 (16.6%) 2 (16.7%) 1.00
Pre-operative aspirin n(%) 3 (25.0%) 8 (66.7%) 0.09
Pre-operative β-blocker n(%) 1 (8.3%) 7 (58.3%) 0.03
Pre-operative CaCB n(%) 1 (8.3%) 5 (41.6%) 0.16
Pre-operative ACEI n(%) 2 (16.7%) 6 (50.0%) 0.19
Pre-operative statin n(%) 3 (25.0%) 9 (75.0%) 0.04

ND: non-diabetes; DM: diabetes; BMI: body mass index; CABG: coronary artery bypass grafting; CaCB: calcium channel blocker; ACEI: angiotensin converting enzyme inhibitor

*

Data expressed as mean ± SD.